Brief: Suven Life Sciences Secures Product Patents In New Zealand And USA
May 29 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SAYS CO SECURES PRODUCT PATENTS IN NEW ZEALAND AND USA
* PATENTS ARE VALID THROUGH 2034
* SAYS PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR
TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE
DISEASES
Source text - http://bit.ly/2LFm1kz
Further company coverage: SUVP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Patient Enrollment In Global Phase-3 Masupirdine Study
India's Suven Life Sciences gains after Masupirdine Phase-3 study completes patient enrollment
Brief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant